Office of Technology Transfer
- Who We Are
- Our Services
- Work With Us
Transforming Pediatric Research Into Life-Changing Solutions
Nemours Children's research leads to life-changing solutions for children. The Office of Technology Transfer (OTT) transforms our research breakthroughs into real-world health care solutions. We help develop new drugs, biomedical devices, therapeutic approaches, and tools that advance how we diagnose and treat children's medical conditions.
Our purpose is to advance children's health by managing and protecting Nemours' intellectual property while creating strategic industry partnerships to bring these innovations to the children who need it.
Our team empowers Nemours associates to bring their innovations to life. We provide comprehensive support across the innovation spectrum: Protecting intellectual property, securing patents, and navigating the path to commercialization.
We actively partner with industry leaders and investors who share our commitment to advancing pediatric health care. Whether you're interested in licensing agreements, research collaborations, or co-development opportunities, we'll help you connect with our world-class investigators and explore our cutting-edge research portfolio.
Nemours Innovation Spotlight
We’re currently partnering with start-up Cellergy Pharma LLC, located in Wilmington, Delaware. Cellergy Pharma is developing a novel CAR-T technology, aimed at treating severe allergic diseases. Chief Science Officer Zhengyu “Mark” Ma, MD, PhD, has invented the company’s CAR-T cell receptors, amid his work leading the T Cell Immunology Research Laboratory at Nemours.
